GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP  by Liu, Zhipei et al.
Biochimica et Biophysica Acta 1793 (2009) 1819–1827
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrGDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent
stabilization of XIAP
Zhipei Liu a,1, Jia Shen a, Kui Pu c, Hugo A. Katus b, Frank Plöger d, Christiane P. Tiefenbacher b,
Xiaobo Chen a,b,⁎,2, Thomas Braun a,⁎
a Department of Cardiac Development and Remodeling, Max-Planck Institute for Heart and Lung Research, Parkstr. 1, 61231 Bad Nauheim, Germany
b Department of Cardiology, University of Heidelberg, INF 410, 69120 Heidelberg, Germany
c Department of Cardiology, the 254th hospital, Tianjin, 300142, P.R. China
d Biopharm GmbH, Czernyring 22, 69115 Heidelberg, Germany⁎ Corresponding authors. Tel.: +49 6032 705 401; fa
E-mail address: thomas.braun@mpi-bn.mpg.de (T. B
1 Current address: Union Gene Test and Health Man
China.
2 Current address: Union Stem Cell and Gene Enginee
0167-4889/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbamcr.2009.09.012a b s t r a c ta r t i c l e i n f oArticle history:
Received 9 April 2009
Received in revised form 2 September 2009
Accepted 14 September 2009
Available online 24 September 2009
Keywords:
Apoptosis
XIAP
BMP2
GDF5
Ubiquitin
BMPR2GDF5 and BMP2, members of the TGF-β superfamily of growth factors, are known to regulate apoptosis in
different cell types either positively or negatively. We wanted to investigate the effects of GDF5 and BMP2 on
vascular smooth muscle cells and mouse embryonic ﬁbroblasts and disclose the mechanism by which GDF5
and BMP2 might exert anti-apoptotic effects. The effect of GDF5 and BMP2 on proliferation and/or
programmed cells death was assessed in isolated human vascular smooth muscle cells and mouse embryonic
ﬁbroblasts. We demonstrate that GDF5 and BMP2 prevent apoptosis induced by serum starvation in mouse
embryonic ﬁbroblasts but not in smooth muscle cells via the BMP receptor 2 (BMPR2), which is often
mutated in hereditary cases of primary pulmonary hypertension. GDF5 and BMP2 stimulate the interaction
of BMPR-2 with XIAP thereby reducing the ubiquitination of XIAP, which results in enhanced protein
stability. The increased concentration of XIAP counteracts apoptosis by binding and inactivating activated
caspases. We conclude that the inhibition of apoptosis in mouse embryonic ﬁbroblasts by BMP2 and GDF5
does not depend on more complex signal transduction pathways such as smad and MAPK signaling but on
direct stabilization of XIAP by BMPR2.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Members of the bone morphogenetic protein (BMP) family elicit
multiple effects, ranging from cell differentiation to regulation of early
embryogenesis. They are also involved in the regulation of apoptosis.
Depending on the cell type and the cellular context BMPsmight either
induce or inhibit apoptosis. Surprisingly little is known about the
interplay of cellular circuits that determine which decision prevails.
Pro-apoptotic effects of BMP2 have been observed in MH60 cells,
which seem to be mediated by activation of TAK1 and subsequent
phosphorylation of p38 MAPK [1]. BMP2 also induces down-
regulation of Bcl-XL in myeloma cells through inactivation of STAT3,
which strongly induces apoptosis [2]. Anti-apoptotic effects of BMP2
have been described in N1511 chondrocytes. In these cells BMP2
prevents apoptosis through induction of Bcl-xL and inhibition of
caspases 3 and 9 [3]. BMP2 does also protect serum-deprived
cardiomyocytes from apoptosis after ischemia–reperfusion via induc-x: +49 6032 705 419.
raun).
agement Center, Tianjin, P.R.
ring Co, Tianjin, P.R.China.
ll rights reserved.tion of Bcl-xL through the smad1 pathway [4]. Incubation of MCF-7
cells with BMP2 under serum-free conditions activates mitogen
activated protein kinases (MAPKs) ERK1/2 and the helix-loop-helix
factor ID-1, a protein that protects cells from apoptosis. Furthermore,
stable overexpression of BMP2 in breast carcinoma cells increased
resistance to hypoxia-induced apoptosis [5]. Multiple molecules and
pathways, such as smad1, 6 and 7, ID1, p38 MAPK, ERK, Bcl-xL, TAK,
p53 and NF-kappaB, are suggested to be involved in the complex
signaling cascades that are initiated by BMP2 and regulate apoptosis.
Growth and differentiation factor (GDF-5) is a member of the BMP
class of proteins and belongs to the TGF-β superfamily of growth factors.
It acts primarily by binding to a speciﬁc receptor-complex made up of
type I and type II serine-threonine receptor kinases, such as ALK6,
BMPR2 and ACTR2a [6] although it has been suggested that GDF5
binding requires an accessory receptor to bind efﬁciently [7]. These
receptors activate smad proteins and/or MAPK to control gene
expression in the nucleus [8]. GDF5 is known to signal via smad1/5
similar to BMP2 while other members of the TGFβ-superfamily such as
TGFβ itself and activin signal via smad2/3 [9]. GDF5 is involved in
skeletal development and joint morphogenesis in human and mouse
and plays a crucial role in the morphogenesis of tendons, ligaments and
bones [10]. So far only a limited number of studies addressed the
function of GDF5 in regulation of apoptosis. Nakahara et al. reported that
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apoptosis inmouse B cell hybridomaHS-72 cells. Interestingly, the effect
ofGDF-5onG1cell cycle arrest and inductionof apotosiswas suppressed
by ectopic expression of smad6 and 7 indicating that the effects of GDF-5
on apoptosis are mainly mediated by Smad proteins [11].
Inhibitors of apoptosis proteins (IAPs), originally found in baculo-
viruses, are present in organisms from viruses to yeast to humans, and
characterized by the presence of one to three tandem baculoviral IAP
repeats (BIR). XIAP is the most potent inhibitor of apoptosis of this
family [12]. XIAP inhibits both the initiator caspase 9 and the effectors
caspases 3 and 7. XIAP can be ubiquitinated and auto-ubiquitinated in
response to DNA damage or other events that lead to induction of
apoptosis [13]. AlthoughXIAPwas recognized as an adaptor protein that
links BMP receptors and TAB1-TAK1, no attempts have been made to
explore the potential role of XIAP in the anti-apoptotic signaling of BMP
receptors [14]. So far, theanti-apoptotic functionofXIAPhas been linked
to TGFβR1 but not to type II receptors or BMP-receptors [15].
To elucidate the role of GDF5 and BMP2 in apoptosis, we induced
programmed cell death in mouse embryo ﬁbroblast cells (MEFs) and
human umbilical vein smooth muscle cell (HUVSMC) by serum
starvation. We found that GDF5 and BMP2 efﬁciently prevent
apoptosis in MEFs but not in HUVSMC, which corresponds to the
expression of BMPR2 in these cells. We propose that the selective
inhibition of apoptosis by GDF5 and BMP2 in MEFs depends on the
association of BMPR2 with XAIP, which prevents ubiquitination and
subsequent degradation of XIAP.
2. Material and methods
2.1. Cell culture and transfection
HUVSMC were isolated from the umbilical cord vein as described
previously [8]. For long term culture, DMEM containing 10% FCS wasFig. 1. GDF5 and BMP2 inhibit serum starvation-induced apoptosis of MEFs. (A) GDF5 and
DMEM containing 2% FCS and 1 μg/ml GDF5 and 80 ng/ml BMP2, respectively. After 1, 2, and
increased the viability of MEF. Values are means±SE (n=3). (B, C) GDF5 and BMP2-incre
containing 2% FCS with different concentrations of GDF5 and BMP2. The viability of cells was
proliferation of MEFs. MEF were cultured in DMEM containing 2% FCS for 1 day. Proliferatio
means±SE (n=3). (E) GDF5 and BMP2 prevent apoptosis of MEFs. MEFs were cultured in s
and y-axes represent exponents of base 10. The degree of apoptosis was quantiﬁed 1 day lused as standard medium. Mouse embryonic ﬁbroblasts (MEF) were
maintained in DMEM medium supplemented with 10% FCS. Trans-
fection of plasmids or siRNA was performed with lipofectamine 2000
(Invitrogen). Expression vector Flag-XIAP was a kind gift from Prof.
Ashwell (NIH, USA) [16]. FLAG-XIAP-K328R contains a lysine to
arginine substitution at position 328 and therefore disrupts a major
auto-ubiquitination site in XIAP as described previously [17]. HA-
BMPR2 was obtained from Prof. Knaus (Institute for Biochemistry, FU
Berlin, Germany) and the ACTR2a vector was purchased from Origene
(Rockville, USA). The sequences of siRNA sequences used are available
from the authors. The use of human cells (HUVSMC) conforms with
the principles outlined in the Declaration of Helsinki. Approval was
granted by the local authorities.
2.2. Viability and proliferation assays
Cell viability was done in a 96-well plate format using the
Sulforhodamine B (SRB) assay [18]. Cell proliferation was accessed
using the BrdU incorporation assay following the instructions of the
manufacturer (Roche).
2.3. Real-time RT-PCR and Western blot analysis
RNA expression levels were determined with a light-cycler system
(Roche), and normalized to the expression of GAPDH. Antibodies
against smad1 and ALK6 were purchased from Santa Cruz; antibodies
against p38 MAPK were obtained from Abcam; antibodies against
phosphorylated smad1 (p-smad1/5/8, #9511), p-p38 MAPK, p-ERK,
p-JNK, JNK, activated-caspase 7, AIP1, caspases 3, 6, 7, 9, 10, cleaved-
PARP were from Cell Signaling; antibodies against caspase-8 were
from Acris; antibody against XIAP and ACTR2a was obtained from
R&D. The antibody against ﬂag was purchased from sigma and the
antibody against BMPR2 from BD.BMP2 increased viability of MEFs under serum starvation. MEFs were incubated with
4 days the survival of MEFs was estimated using the SRB assay. GDF5/BMP2 signiﬁcantly
ased viability of MEFs in a dose dependent manner. MEF were incubated with DMEM
measured after 4 days. Values are means± SE (n=3). (D) GDF5 and BMP2 did not affect
n was determined 1 day after addition of 1 μg/ml GDF5 or 80 ng/ml BMP2. Values are
erum-free medium with 1 μg/ml GDF5 and 80 ng/ml BMP2 respectively Numbers on x-
ater using the annexin V assay. Values are means±SE (n=3). ⁎pb0.05 ⁎⁎pb0.01.
Fig. 2. Expression of different apoptosis related protein in serum starvation-induced apoptosis. Different anti-apoptotic and pro-apoptotic proteins were tested by Western blot
analysis 6, and 24 h after serum starvation. Active-caspase 3, active-caspase 7 and cleaved-PAPR were down-regulated by treatment of cells with GDF5 and BMP2. The expression of
XIAP, caspase 3 and caspase 7 did not affected by the treatment. Values are means± SE (n=3). ⁎pb0.05.
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MEF cells were seeded in 6-well plates and transfected with the
different constructs. Two days after transfection, cells were incubated
with serum-free medium for 6 h, combined with GDF5 (1 μg/ml) or
BMP2 (80 ng/ml). The number of apoptotic cells was determined by
FACS analysis using the Annexin-V-FLUOS Staining Kit (Roche). Cell
lysates for immunoprecipitations were isolated 2 days after transfec-
tions. The Co-IP Kit from Pierce was used to precipitate protein
complexes. Primary antibody linked beads were added and incubated
overnight. Precipitated proteins were eluted from the beads and
measured by Western blot analysis.
2.5. Statistical analysis
Average values and standard errors were calculated from at least
three independent experiments. Statistical analysis was performed
using the Sigmaplot 2001 software. A p-value lower than 0.05 was
considered to be signiﬁcant.
3. Results
3.1. GDF5 or BMP2 support growth of MEF under low serum conditions
via inhibition of apoptosis and not by stimulation of proliferation
Previous studies have indicated anti-apoptotic as well as pro-
apoptotic functions of members of the BMP-family of growth factors
on different cell types. We investigated the effects of two members of
this family, GDF5 and BMP2, on cellular growth of mouse embryonic
ﬁbroblast cells (MEF) at low serum conditions (2% FCS). After
incubation with GDF5 (1 μg/ml) or BMP2 (80 ng/ml) for 1, 2, or
4 days, cell viability was determined using the SRB assay. GDF5 or
BMP2-treated cells showed an increased viability compared tountreated controls, which resulted in a doubling of the number of
living cells after 4 days (Fig. 1A). The effect was dose dependent for
both GDF5 and BMP2 (Fig. 1B, C). We next determined whether this
effect was due to increased proliferation by measurement of the rate
of BrdU incorporation. Neither GDF5 nor BMP2 had a signiﬁcant effect
on proliferation (Fig. 1D) indicating that the increase of the number of
viable cells was due to an inhibition of cell death. In order to avoid
anti-apoptotic effects exerted by serum, we employed a serum-free
culture system and repeated our measurements. The lack of serum
resulted in higher levels of cell death compared to cultures
supplementedwith 2% FCS and hence yieldedmore signiﬁcant results.
Double staining using annexin V and PI indicated that the addition of
GDF5 or BMP2 led to a signiﬁcant decrease of the number of apoptotic
cells (Fig. 1E). Similar results were also obtained by measuring
activated caspases 3, 7, and PARP (data not shown). Taken together,
our data indicate that GDF5 and BMP2 increase the number of MEF
under low serum conditions due to protection from apoptosis but not
due to stimulation of proliferation. To further characterize the effects
of GDF5 or BMP2 on apoptosis, MEF were harvested and serum
starved for 6, and 24 h and treated with GDF5 or BMP2. Activated
caspases 3, 7 and their downstream target, cleaved PARP were
monitored as molecular markers for apoptosis (Fig. 2). The expression
of activated caspases 3, 7 and cleaved PARP was signiﬁcantly lower in
GDF5 or BMP2-treated cells, which further conﬁrmed the anti-
apoptotic potential of GDF5 and BMP2. It was also interesting to
note that BMP2 and GDF5 maintained or even increased the levels of
uncleaved caspases 3, 7, 9 and of XIAP (Fig. 2). Next, we examined the
activity of the two main apoptotic signal transmission pathways
during serum starvation and GDF5/BMP2 treatment (Fig. 2). Caspases
8 and 10 were chosen as indicators for the death receptor pathway
and activated caspase 9 as an indicator of the mitochondrium-
mediated pathway. We detected a stabilization of caspase 9 after
treatment with GDF5 and BMP2 while the expression levels of
Fig. 3. GDF5 and BMP2 do not prevent apoptosis of HUVSMCs. (A) GDF5 and BMP2 did
not protect serum starvation induced apoptosis of HUVSMCs. HUVSMCswere incubated
with serum-free DMEM containing 1 μg/ml GDF5 or 80 ng/ml BMP2 and analyzed after
24 h by the Annexin V apoptosis assay (n=3). (B) GDF5 and BMP2 did not prevent
down-regulation of XIAP in HUVSMCs. HUVSMCs were incubated with serum-free
DMEM containing 1 μg/ml GDF5 or 80 ng/ml BMP2 for 24 h. XIAP expression was
monitored by Western blot analysis. NC, ﬁrst lane: DMEM with 10% FCS. NC, second
lane: serum-free DMEME without addition of GDF5 and BMP2. (C) Western blot
analysis of the expression of BMP receptors in HUVSMCs andMEFs. ACTR2was detected
slightly below the 60 kDa and BMPR2 between the 100 and 120 kDa molecular weight
marker, which roughly corresponded to the expected molecular weight.
1822 Z. Liu et al. / Biochimica et Biophysica Acta 1793 (2009) 1819–1827caspases 8 and 10 were unchanged. This observation indicated that
serum starvation induced apoptosis in MEFs mainly through the
mitochondrium related pathway and that GDF5 and BMP2 inhibited
this process. Interestingly, GDF5 or BMP2 did not exert anti-apoptoticFig. 4. GDF5 and BMP2 stabilize XIAP to prevent apoptosis. (A, B) XIAP inhibited activation o
(B) or XIAP expression vector (C). After 2 days MEF were incubated in serum-free DMEM for
NC: cells incubated in DMEMwith 10% FCS without GDF5 and BMP2. (C) XIAP inhibited apop
and a control vector. The rate of apoptosis was determined using the annexin V assay 1 day
BMP2. Values are means±SE (n=3), ⁎pb0.05. (D) GDF5 and BMP2 did not induce XIAP mR
80 ng/ml BMP2. Real-time PCR was performed to determine the expression level of XIAP mR
GDF5 and BMP2.effects on HUVSMC during serum starvation (Fig. 3A) and did also not
prevent down-regulation of XIAP (Fig. 3B). We reasoned that the
differential anti-apoptotic activity of GDF5 and BMP2 on MEFs and
HUVSMCs might be due to differences in the expression level of BMP
receptors. Western blot analysis revealed that the protein level of
BMPR2was signiﬁcant lower in HUVSMC compared to MEFS (Fig. 3C),
which suggests that BMPR2 might play a dominant role in BMP2/
GDF5-mediated regulation of apoptosis in MEFs. These ﬁndings are in
agreement with previous reports, which described an expression of
only low amounts of BMPR2 mRNA in HUVSMC by RT-PCR [8].
3.2. GDF5 and BMP2 inhibit apoptosis via stabilization of XIAP
One of the most potent inhibitors of apoptosis is XIAP, which is a
member of the IAP family of E3 ubiquitin ligases [19]. XIAP selectively
binds to and inhibits activation of distinct caspases, such as caspases 3,
7, 9, and 12 but not of caspase 1, 6, 8, or 10 and thereby blocks death
signals transmitted via the intrinsic (mitochondrial) and extrinsic
(death receptor) apoptotic pathways [20,21]. Since XIAP plays an
important role in the regulation of mitochondria-mediated apoptosis,
we investigated the role of XIAP in MEFs after serum starvation by
siRNA mediated knock-down and overexpression. Activated caspases
3, 7 and cleaved PARP were used as indicators of apoptosis. As shown
in Fig. 2 XIAP was down-regulated after 6 h of serum starvation while
other the concentration of other effecters of apoptosis such BAX, Bcl2,
PUMA, p53 did not change (data not shown). Interestingly, treatment
of MEFs with GDF5/BMP2 efﬁciently prevented this down-regulation
and inhibited apoptosis. Conversely, the knock-down of XIAP resulted
in enhanced presence of activated caspases 3, 7 and PARP and
increased apoptosis, which could not be rescued by addition of GDF5
or BMP2 (Fig. 4A) while the overexpression of XIAP inhibited
apoptosis induced by serum depletion (Fig. 4B). Concomitant over-
expression of XIAP and treatment with GDF5 or BMP2 did not result in
a further decrease of apoptosis indicating that GDF5/BMP2 might actf caspases 3 and 7 induced by serum starvation. MEFs were transfected with XIAP siRNA
6 h and tested for the expression of apoptosis markers byWestern blot analysis, (n=3).
tosis induced by serum starvation. MEF were transfected with a XIAP expression vector
after treatment of cells with serum-free DMEM containing 1 μg/ml GDF5 or 80 ng/ml
NA expression. MEF were cultured in DMEM containing 0.5% FCS and 1 μg/ml GDF5 or
NA. Values are means±SE (n=3). “C” in (C, D): serum starved cells without addition of
1823Z. Liu et al. / Biochimica et Biophysica Acta 1793 (2009) 1819–1827in the same pathway (Fig. 4C). Our results also raised the question
whether GDF5 and BMP2 regulate the stability of the XIAP protein or
stimulate transcription of the XIAP gene. To approach the mechanism
by which GDF5 and BMP2 regulate XIAP we ﬁrst examined the levels
of XIAP-mRNA after treatment of cells with high concentrations of
GDF5 and BMP2 by real-time RT-PCR. We found that the mRNA levels
of XIAP remained stable during starvation, independent on GDF5/
BMP2 treatment (Fig. 4D), strongly suggesting that XIAP is regulated
at the post-transcriptional level probably by ubiquitin-mediated
protein degradation.
3.3. The intracellular concentration of XIAP is governed by its
ubiquitination status and interaction with BMPR2
To determine whether XIAP is ubiquitinated in MEFs we recovered
Flag-tagged XIAP by immunoprecipitation from transfected cells
followed by Western blot analysis. The antibody directed against
the Flag-tag identiﬁed an unmodiﬁed Flag-XIAP fusion protein of
approximately 60 kDa as well as several additional bands of higher
molecular weight, which most likely represented different ubiquiti-
nated forms of XIAP (Fig. 5A). This assumption was conﬁrmed usingFig. 5. XIAP is regulated by ubiquitination and forms complexes with BMPR2. (A, B) Ubiqu
immunoprecipitation/Western blot analysis 2 days later. MEF were lysed with IP lysis buffer
as indicated (n=3). Note that ubiquitination of XIAP resulted in multiple bands. The 60 kD
the ubiquitin moiety has a MW of 12 kDa), 84 kDa is Flag-XIAP-Ub-Ub, 96 kDa is Flag-XIAP-U
Ub-XIAP variant. (C) Inhibition of proteasomal activity increased the concentration of ubiqu
2 days after transfection before combined immunoprecipitation/Western blot analysis us
ubiquitination site increased the steady-state protein level of XIAP. MEF were transfected wi
XIAP (X-K328R), which lacks a major ubiquitination site at position 328. After 2 days MEF
Western blot analysis (n=3). (E) GDF5 and BMP2 stabilized XIAP by inhibiting ubiquitinat
GDF5 or BMP2. Cell lysates were obtained 6 h later (n=3). (F) GDF5 and BMP2 increased th
After 2 days, MEF were incubated with DMEM containing 0.5% FCS, with or without 1 μg/ml
ALK6 (n=3). NC: negative control without additional growth factors. (G, H) GDF5 and BMP
XIAP. MEFs were transfected with vectors ﬂag-XIAP, HA-BMPR2, ACTR2a. After 2 days, ME
80 ng/ml BMP2. MEF were lysed with IP lysis buffer and precipitated (n=3). NC: negativanti-ubiquitin antibodies, which reacted with the higher molecular
forms of XIAP but not with the 60 kDa band (Fig. 5B). Inhibition of
proteasomal activity following treatment with the proteasomal
inhibitor MG132 further increased the concentration of non-ubiqui-
tinated and ubiquitinated XIAP indicating that the concentration of
XIAP is controlled at the posttranslational level (Fig. 5C). We next
analyzed whether removal of a major ubiquitination site of XIAP
would rescue the down-regulation of XIAP protein evoked by the shift
to serum-free culture conditions. Western blot analysis of unmodiﬁed
XIAP and of K328R-XIAP, which contained an arginine instead of a
lysine at position 328 of XIAP, revealed a clear increase of the
concentration of mutant compared to the wild-type protein under
serum-free condition suggesting that the concentration of XIAP
indeed depended on its ubiquitination status (Fig. 5D). We also
compared the effects of an inhibition of the proteasomal activity,
which is mainly responsible for the degradation of ubiquitinated
proteins, to the treatment of MEFs with BMP2 and/or GDF5.
Treatment of serum-starved MEFs with MG132 prevented loss of
XIAP and inhibited apoptosis essentially mimicking the effects of
GDF5 and BMP2 (Fig. 5E). Addition of GDF5 or BMP2 to cultures
treated with MG132 had no further effects on XIAP levels suggestingitination of XIAP in MEFs. MEFs were transfected with XIAP and tested by combined
, precipitated with anti-FLAG, and probed with anti-FLAG and anti-ubiquitin antibodies
a band corresponds to (non-ubiquitinated) Flag-XIAP, 72 kDa is Flag-XIAP-Ub1 (since
b-Ub-Ub. It seems indeed likely that the band between the 70 and 85 kDa markers is a
itinated and non-ubiquitinated XIAP. MEF were pretreated with MG132 (10 μM) for 8 h
ing anti-FLAG antibodies to detect transfected XIAP (n=3). (D) Mutation of a major
th pcDNA expression vectors carrying no insert, wild-type XIAP, or a mutated version of
were incubated in serum-free DMEM for 6 h and tested for the expression of XIAP by
ion. MEF were pretreated with MG132 (10 μM) for 8 h followed by an incubation with
e binding afﬁnity between ALK6 and XIAP. MEF were transfected with Flag-XIAP vector.
GDF5 or 80 ng/ml BMP2. MEF were lysed with IP lysis buffer and precipitated with anti-
2 increased the binding afﬁnity between BMPR2 and XIAP but not between ACTR2a and
F were incubated with DMEM containing 0.5% FCS, with or without 1 μg/ml GDF5 or
e control without additional growth factors.
Fig. 6. GDF5 stabilizes XIAP via BMPR2 and not via ACTR2a. (A, B) GDF5 and BMP2 inhibited down-regulation of XIAP via BMPR2 and not via ACTR2a. The anti-apoptotic function of
GDF5 and BMP2 was tested by Western blot analysis 2 days after transfection of MEFs with BMPR2 siRNA (A) and ACTR2a siRNA (B) (n=3). Cells were starved for 24 h before
Western blot analysis. (C) GDF5 and BMP2 prevented apoptosis via activation of BMPR2. MEFs were transfected with BMPR2 and ACTR2a siRNA and analyzed for signs of apoptosis
using the Annexin V apoptosis assay. Values are means±SE (n=3), ⁎pb0.05. Cells were starved for 6 h before the Annexin V assay. (D) Overexpression of BMPR2 increased the
steady-state levels of XIAP. BMPR2 and XIAP were transfected into MEFs and tested byWestern blot analysis 2 days later. Overexpression of BMPR2 increased protein concentrations
of XIAP while transfection of XIAP had no effects on the expression level of BMPR2 (n=3).
1824 Z. Liu et al. / Biochimica et Biophysica Acta 1793 (2009) 1819–1827that GDF5 and BMP2 inhibited apoptosis most likely via stabilization
of XIAP.
GDF5 and BMP2-mediated signal transduction occurs via type
and type II transmembrane serine/threonine kinase receptors. More
precisely, ALK6, BMPR2, and ACTR2a have been reported to act as
speciﬁc receptors of GDF5. It has also been shown that XIAP
participates in BMP signaling pathway as a positive regulator, which
links BMP receptors and TAB1-TAK1 [14]. Therefore, we reasoned that
XIAP might be directly bound and stabilized by BMP-receptors. Since
ALK6 serves as a type I receptor both for GFD5 and BMP2 we
performed co-immunoprecipitation experiments of XIAP and ALK6
after treatment of MEFs with BMP2 or GDF5. We found that XIAP was
efﬁciently precipitated together with ALK6 indicating a strong
interaction of both molecules (Fig. 5F). We next wanted to know
which of the two type 2 receptors for GDF5, ACTR2a or BMPR2
participated in complex formation leading to stabilization of XIAP. In
this context it is important to point out that BMPR2 was strongly
expressed in MEFs that responded to GDF5 treatment by increased
levels of XIAP and inhibition of apoptosis but not in HUVSMC, which
did not show this response. To identify which type 2 receptor interacts
with XIAP, we transfected MEFs with HA-BMPR2, Flag-XIAP and
ACTR2a. We found that treatment of MEFs with GDF5 and BMP2
resulted in increased co-immunoprecipitation of XIAP and BMPR2 but
not of ACTR2a (Fig. 5G, H).
To further study the impact of BMPR2 or ACTR2 on the regulation
of XIAP protein stability and on the rate of programmed cell death of
MEFs performed knocked-down experiments using siRNAs speciﬁc
for BMPR2 or ACTR2a. Interestingly, siRNA-mediated knock-down of
BMPR2 inhibited the anti-apoptotic effects of GDF5 and BMP2 and
prevented stabilization of XIAP while the knock-down of ACTR2a
caused no obvious effects (Fig. 6A, B). FACS-analysis revealed no
signiﬁcant decrease of Annexin V positive, PI negative cells in BMPR2
knock-down MEFs compared to wild type and ACTR2a knock-down
cells (Fig. 6C), which was in line with our hypothesis that the knock-down of BMPR2 but not ACTR2a abrogated inhibition of apoptosis.
Since the knock-down of the BMPR2 receptor promoted apoptosis
(Fig. 6C) we concluded that the BMPR2 receptor exerted a certain
basic activity, which stabilized XIAP even in the absence of
exogenously added BMP proteins. To further corroborate the role of
BMPR2 in the regulation of protein levels of XIAP we overexpressed
BMPR2 and XIAP in MEFs. Co-overexpression of BMPR2 and XIAP
resulted in enhanced levels of XIAP protein compared to over-
expression of XIAP alone while the concentration of BMPR2 was not
affected by the increased presence of XIAP (Fig. 6D). Both experi-
mental approaches clearly suggested that the level of XIAP protein
directly corresponded to the concentration of BMPR2.
Stimulation of MEFs with GDF5 and BMP2 might not only
stimulate the direct interaction of XIAP with BMPR2 but might also
lead to the activation other intracellular signaling pathways, which
might indirectly affect the stability of XIAP and/or control
programmed cell death. To investigate this possibility we analyzed
the activation of several well-known signal transduction pathways in
response to treatment with GDF5 or BMP2. We found that either
growth factor efﬁciently stimulated phosphorylation of smad1, p38
MAPK and ERK (Fig. 7A, B). Although BMP2 signaling often leads to
the concomitant activation of p38 MAPK and JNK in several different
cell types, we did not detect a clear activation of JNK in MEFs. To
investigate whether any of the activated pathways contributed to the
anti-apoptotic effects exerted by GDF5 and BMP2 that resulted in
stabilization of XIAP, several different inhibitors and siRNA molecules
were used. MEFs were treated with SB203580 or U0126 (Fig. 7C),
which block p38 MAPK and ERK signaling, respectively, and
transfected with a siRNA against smad1 (Fig. 7D). None of these
reagents prevented up-regulation of XIAP by GDF5 and BMP2
indicating that stabilization of XIAP occurred independent of
smad1, p38 MAPK or ERK signaling. To exclude that inhibition of
p38 MAPK is compensated by ERK signaling and vice versa we also
examined the effects of a combined treatment with SB203580 or
Fig. 7. Stabilization of XIAP by GDF5 and BMP2 does not depend on smad1 or MAPK signaling. (A, B) Analysis of phosphorylation events trigged by GDF5 (A) and BMP2 (B). MEFs
were pretreated by DMEM containing 0.5% FCS 1 day before addition of GDF5 and BMP2. Cells were harvested at indicated time points for Western blot analysis (n=3). (C, D)
Stabilization of XIAP by GDF5 and BMP2 occurred independently of smad1 and MAPK-signaling. MEFs were pretreated with SB203580 (10 μM), U0126 (10 μM) (C) or transfected
with smad1 siRNA (D). Cell lysates forWestern blots analysis were harvested after incubation with GDF5 and BMP2 for 6 h (n=3). (E, F, G) Inhibition of smad and/orMAPK signaling
does not affect GDF5 and BMP2-mediated reduction of apoptosis inMEFs. MEFs were serum-starved and treated with Dorsomorphin (5 μM), UO126 (10 μM), SB203580 (10 μM), and
a combination of UO126 and SB203580 before addition of BMP-2 or GDF-5. Inhibition of apoptosis was determined after incubation with GDF5 and BMP2 for 6 h by detection of
activated caspase-3 (a-cas3) usingWestern blot analysis (E) and by the annexin V assay (F). Values are means±SE (n=3). ⁎pb0.01 ⁎⁎pb0.05 ⁎⁎⁎pb0.001. (G) Serum starved MEFs
were transfected with smad4 speciﬁc siRNA or scrambled control siRNA before treatment with BMP2 or GDF5. Cell lysates were prepared for Western blot analysis after treatment
with GDF5 and BMP2 for 6 h (n=3). Note that the knock-down of smad4 did not affect BMP2 or GDF5-mediated reduction of activated caspase 3. (NC=negative control, DMEM
containing 10% FCS without BMP2 or GDF5).
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and ERK signaling did not counteract BMP2 and GDF5-mediated
inhibition of apoptosis. In contrast, dorsomorphin, which selectively
inhibits the BMP type I receptors ALK2, ALK3 and ALK6 and thus
blocks BMP-mediated SMAD1/5/8 phosphorylation [22] prevented
BMP2 and GDF5-mediated inhibition of apoptosis as measured by
expression of activated caspase 3 (Fig. 7E). Although the presence of
activated caspase 3 is a reliable marker for apoptosis we also
investigated the effect of different inhibitors using the Annexin-V-
FLUOS assay. Essentially, we obtained very similar results compared
to the activated caspase 3 assay although it became more evident that
addition of dorsomorphin caused an increase of apoptosis in serum
starved cells (Fig. 7F), which was also evident in the Western blot
analysis for activated caspase 3 (Fig. 7E). Addition of BMP2 or GDF5
did not inhibit apoptosis in the presence of dorsomorphin compared
to non-treated, serum-starved cells but reduced the number of
apoptotic cells compared to dorsomorphin-treated, serum-starved
cells At present we do not have a compelling explanation for this
phenomenon, which might be caused by unspeciﬁc effects of
dorsomorphin. Finally, we wanted to conﬁrm that the anti-apoptotic
effects of BMP2 and GDF5 were not mediated via smad-signaling.
Although the knock-down of smad1 prevented detection of phos-
phorylated p-smad1/5/8 (data not shown), which makes a compen-
sation of the reduction of smad1 by smad5 unlikely the possibility
remained that other receptor-smads might compensate for the loss of
smad1. Therefore, we employed smad4 siRNA to indirectly block the
action of receptor-smads. Again, BMP2 and GDF5-mediated inhibition
of apoptosis was not affected by this manipulation (Fig. 7G), which
further supported our view that stabilization of XIAP is the decisive
element in this process.
4. Discussion
We have shown that GDF5 and BMP2 exert anti-apoptotic effects
in MEFs in response to serum starvation. The anti-apoptotic function
of GDF5 and BMP2 seemed to be caused by association of XIAP with
ALK6/BMPR2, which prevented ubiquitin-mediated degradation of
XIAP and thus maintained functional levels of XIAP.
Although several studies have addressed the pro- and anti-
apoptotic functions of BMPs, our report is the ﬁrst to demonstrate
that BMPs can stabilize XIAP, which is the founding member of the
IAP (inhibitor of apoptosis protein) family. Members of the IAP
family play important roles in the regulation of apoptosis by
inhibiting activation of caspases and blocking both death receptor
and mitochondria mediated apoptosis pathways[12,23]. The XIAP
protein contains three BIR domains and a ring domain. The third BIR
domain strongly inhibits the catalytic activity of caspase 9, whereas
the linker sequences, which precede the second BIR domain,
selectively target caspase 3 or 7. Hence, XIAP inhibit both the
initiator caspase 9 and the effectors caspases 3 and 7. XIAP has a ring
domain at its C terminus, which acts as an E3 ubiquitin ligase
targeting cellular proteins for degradation by ubiquitin-dependent
proteolysis. XIAP stimulates proteosomal degradation of caspase 3
and of secondary modulators of apoptotic proteases in response to
anti-apoptotic stimuli. At the same time it limits its own action by
promotion of self-degradation. Our data indicate that the concen-
tration of XIAP was maintained by GDF5 or BMP2 in response to
serum starvation, which led to stabilization of procaspase 9 and
inhibition of the activity of caspase 3 and caspase 7. Eventually, this
resulted in reduced cleavage of PARP, a hallmark of apoptosis, in
MEF. Similar effects were achieved by treatment of MEFs with
MG132, a proteosomal inhibitor, which corroborated previous
results describing a down-regulation of XIAP via ubiquitin-mediated
protein degradation in response to apoptotic stimuli [24]. Our results
clearly show that stabilization of XIAP is critically important for the
anti-apoptotic effects of GDF5 and BMP2.Another important ﬁnding was our observation that GDF5 and
BMP2-mediated stabilization of XIAP occurred via the BMP type 2
receptor, BMPR2. Although two BMP type 2 receptors, BMPR2 and
ACTR2a, which bind GDF5, are expressed in MEFs, only the knock-
down of BMPR2 but not ACTR2a blocked the anti-apoptotic function of
BMP proteins in MEFs. This observation did also nicely correspond to
our ﬁndings in HUVSMC. Most likely the failure of GDF5 and BMP2 to
protect XIAP from down-regulation by serum starvation in HUVSMC
was caused by the low level of BMPR2 in HUVSMC. In this context it is
interesting to note that BMP-2 reduces apoptosis in endothelial
progenitor cells (EPC) from normal subjects but not in EPCs isolated
from patients with idiopathic pulmonary arterial hypertension
(IPAH), which carry loss-of-function mutations of BMPR2. Similarly,
the knock-down of BMPR2 increases the level of apoptosis in
endothelial cells [25]. Our data show that BMPR2 but not ACTR2a is
instrumental to prevent apoptosis correspond to clinical ﬁndings
describing mutations of BMPR2 and not of ACTR2a in patients with
primary pulmonary hypertension [26,27]. At present it is not clear
why loss-of-function mutations in the BMPR2 gene lead to increased
apoptosis of pulmonary endothelial and smooth muscle cells [25,28].
Since BMPR2 is highly expressed in endothelial cell it is tempting to
speculate that pulmonary endothelial and smooth muscle cells
encounter strong stimulation of apoptosis, which is constantly
balanced by a high activity of BMPR2 signaling. According to this
model an inactivation of BMPR2 will lead to degradation of XIAP and
induce apoptosis. Further characterization of distinct functions of
BMP-receptors and tissue speciﬁc factors, which might modulate the
effects of GDF5 and BMP2, will help to unveil the speciﬁc role of these
signaling pathways in the maintenance of tissue homeostasis.Acknowledgements
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